Elaine O'Hara - Mar 1, 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, Chief Strategy Officer
Signature
/s/Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Mar 1, 2025
Transactions value $
-$136,146
Form type
4
Date filed
3/4/2025, 06:39 PM
Previous filing
Mar 5, 2024
Next filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +19.6K +137.79% $0.00 33.8K Mar 1, 2025 Direct
transaction NVAX Common Stock Options Exercise $0 +40K +118.26% $0.00 73.8K Mar 1, 2025 Direct
transaction NVAX Common Stock Tax liability -$44.8K -5.38K -7.28% $8.33 68.5K Mar 1, 2025 Direct
transaction NVAX Common Stock Tax liability -$91.4K -11K -16.02% $8.33 57.5K Mar 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -19.6K -50% $0.00 19.6K Mar 1, 2025 Common Stock 19.6K $0.00 Direct F1
transaction NVAX Restricted Stock Units Options Exercise $0 -40K -33.33% $0.00 80K Mar 1, 2025 Common Stock 40K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.